Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. Biochemical and histopathological assessment of liver in a rat model of metabolic syndrome induced by high‐carbohydrate high‐fat diet
- Sok Kuan Wong
- Kok‐Yong Chin
- Fairus Ahmad
- Soelaiman Ima‐Nirwana
2. Changes in the structure of the heart and blood pressure after a period of concurrent endurance-resistance training in patients with chronic heart failure
- Zahra Mahmoodi
- Ramin Shabani
- Zahra Hojjati Zidashti
- Mahboubeh Gholipour
3. The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease
- Hadi Emamat
- Forough Foroughi
- Hassan Eini-Zinab
- Azita Hekmatdoost
4. Aucubin administration suppresses STING signaling and mitigated high-fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice
- Yu Liu
- Yan Zhang
- Huanhuan Zhu
- Wenzhi Shen
- Zheng Chen
- Jian Bai
- Tian Shuang
- Qi Chen
5. Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non‐alcoholic fatty liver disease
- Joan Khoo
- John C. Hsiang
- Ranu Taneja
- Seok‐Hwee Koo
- Gaik‐Hong Soon
- Carmen J. Kam
- Ngai‐Moh Law
- Tiing‐Leong Ang
6. Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial
- Fatemeh Dashti
- Seyed Moayed Alavian
- Amir Ali Sohrabpour
- Sara Ebrahimi Mousavi
- Seyed-Ali Keshavarz
- Ahmad Esmaillzadeh
7. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- Forouzan Faghihzadeh
- Payman Adibi
- Azita Hekmatdoost
8. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease
- Saeede Saadati
- Behzad Hatami
- Zahra Yari
- Mohammad Amin Shahrbaf
- Sareh Eghtesad
- Asieh Mansour
- Hossein Poustchi
- Mehdi Hedayati
- Morteza Aghajanpoor-pasha
- Amir Sadeghi
- Azita Hekmatdoost
9. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study
- Zahra Yari
- Mehran Rahimlou
- Tannaz Eslamparast
- Naser Ebrahimi-Daryani
- Hossein Poustchi
- Azita Hekmatdoost
10. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- Somayyeh Asghari
- Mohammad Asghari-Jafarabadi
- Mohammad-Hossein Somi
- Seyed-Mostafa Ghavami
- Maryam Rafraf
11. Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
- Zahra Darabi
- Mina Darand
- Zahra Yari
- Mehdi Hedayati
- Amirhosein Faghihi
- Shahram Agah
- Azita Hekmatdoost
12. Efficacy of Portulaca oleracea supplementation with a combination training program on the levels of some blood factors and health indicators of obese females with non- alcoholic fatty liver disease
- Narges Aliniya
- Alireza Elmieh
- Mohammadreza Fadaei Chafy
13. La diète cétogène : bénéfique pour la stéatose hépatique non alcoolique ?
- Manila Sophasath
- Yvette Mukaneza
- Geneviève Huard
- Chantal Bémeur
14. The association between dietary acid load and odds of non-alcoholic fatty liver disease: A case-control study
- Hadi Emamat
- Hossein Farhadnejad
- Hossein Poustchi
- Farshad Teymoori
- Alireza Bahrami
- Azita Hekmatdoost
15. The Effect of Alpha-Lipoic Acid on Liver Function and Metabolic Markers in Obese Patients with Non-Alcoholic Fatty Liver Disease: A Double - Blind Randomized Controlled Trial
- Farshad Amirkhizi
- Soudabeh Hamedi-Shahraki
- Sonya Hosseinpour-Arjmand
- Mehrangiz Ebrahimi-Mameghani
16. 腸管不全とシトルリン投与
17. Comments on “The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease”
- Makan Cheraghpour
- Azita Hekmatdoost
- Alireza Ghaemi
18. Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT
- Charu Arora
- Anita Malhotra
- Piyush Ranjan
- Vishwajeet Singh
- Namrata Singh
- Shalimar
- S. N. Dwivedi
- Naval K. Vikram
19.
20. The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease
- Hadi Emamat
- Forough Foroughi
- Hassan Eini–Zinab
- Mohsen Taghizadeh
- Marjan Rismanchi
- Azita Hekmatdoost
21. Health benefits of Mediterranean diet in nonalcoholic fatty liver disease
- Ludovico Abenavoli
- Laura Di Renzo
- Luigi Boccuto
- Nuha Alwardat
- Santo Gratteri
- Antonino De Lorenzo
22.
23. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- Forouzan Faghihzadeh
- Peyman Adibi
- Rahmatollah Rafiei
- Azita Hekmatdoost
24. Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study
- Antonella Mirizzi
- Isabella Franco
- Carla Maria Leone
- Caterina Bonfiglio
- Raffaele Cozzolongo
- Maria Notarnicola
- Vito Giannuzzi
- Valeria Tutino
- Valentina De Nunzio
- Irene Bruno
- Claudia Buongiorno
- Angelo Campanella
- Valentina Deflorio
- Annamaria Pascale
- Filippo Procino
- Paolo Sorino
- Alberto Rubén Osella
25. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD
- Amir Hadi
- Hamed Mohammadi
- Maryam Miraghajani
- Ehsan Ghaedi
26. Nigella sativa and Non-Alcoholic Fatty Liver Disease: A Review of the Current Evidence
- Mina Darand
- Seyed Moayed Alavian
- Azita Hekmatdoost
27. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
- Chiara Gelli
- Mirko Tarocchi
- Ludovico Abenavoli
- Laura Di Renzo
- Andrea Galli
- Antonino De Lorenzo
28. Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
- Zeinab Mokhtari
- Deanna L Gibson
- Azita Hekmatdoost
29.
30. Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease
- Azita Hekmatdoost
- Ali Shamsipour
- Mohammad Meibodi
- Newsha Gheibizadeh
- Tannaz Eslamparast
- Hossein Poustchi
31. Hepatoprotective Effects of Insect Extracts in an Animal Model of Nonalcoholic Fatty Liver Disease
- A-Rang Im
- Won-Kyung Yang
- Yang-Chun Park
- Seung Kim
- Sungwook Chae
32. Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation
- Maryam Noori
- Bahar Jafari
- Azita Hekmatdoost
33.
34. Effects of Alpha-Lipoic Acid Supplementation on Oxidative Stress Status in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double Blind, Placebo-Controlled Clinical Trial
- Farshad Amirkhizi
- Soudabeh Hamedi-Shahraki
- Sonya Hosseinpour-Arjmand
- Elnaz Vaghef-Mehrabany
- Mehrangiz Ebrahimi-Mameghani
35. <i>Elaeagnus mollis</i> Oil Attenuates Non-alcoholic Fatty Disease in High-fat Diet Induced Obese Mice via Modifying the Expression of Lipid Metabolismrelated Genes
- Caixia Guo
- Jinping Qiao
- Shengwan Zhang
- Meiping Li
- Juan Li
- Shaimaa Hatab
36. Patient initiation and maintenance of GLP-1 RAs for treatment of obesity: a narrative review and practical considerations for primary care providers
- Angela Fitch
- Amy Beth Ingersoll
37. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future
- Mehran Rahimlou
38. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
- Fatemeh Mofidi
- Hossein Poustchi
- Zahra Yari
- Babak Nourinayyer
- Shahin Merat
- Maryam Sharafkhah
- Reza Malekzadeh
- Azita Hekmatdoost
39. A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial
- Mitra Hariri
- Ali Gholami
- Seyed Reza Mirhafez
- Mohammad Bidkhori
- Amirhosein Sahebkar
40. Effects of Calorie Restricted Diet on Oxidative/Antioxidative Status Biomarkers and Serum Fibroblast Growth Factor 21 Levels in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Controlled Clinical Trial
- Somayyeh Asghari
- Mahsa Rezaei
- Maryam Rafraf
- Mahdiyeh Taghizadeh
- Mohammad Asghari-Jafarabadi
- Maryam Ebadi
41. Legume intake and risk of nonalcoholic fatty liver disease
- Alireza Bahrami
- Farshad Teymoori
- Tannaz Eslamparast
- Golbon Sohrab
- Ehsan Hejazi
- Hossein Poustchi
- Azita Hekmatdoost
42. Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study
- B. Dustin Pooler
- Curtis N. Wiens
- Alan McMillan
- Nathan S. Artz
- Alexandra Schlein
- Yesenia Covarrubias
- Jonathan Hooker
- Jeffrey B. Schwimmer
- Luke M. Funk
- Guilherme M. Campos
- Jacob A. Greenberg
- Garth Jacobsen
- Santiago Horgan
- Tanya Wolfson
- Anthony C. Gamst
- Claude B. Sirlin
- Scott B. Reeder
43. Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial
- Mina Darand
- Zahra Darabi
- Zahra Yari
- Saeedeh Saadati
- Mehdi Hedayati
- Ahmad Khoncheh
- Behnam Hosseini-Ahangar
- Seyed moayyed Alavian
- Azita Hekmatdoost
44. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
- Saeede Saadati
- Amir Sadeghi
- Asieh Mansour
- Zahra Yari
- Hossein Poustchi
- Mehdi Hedayati
- Behzad Hatami
- Azita Hekmatdoost
45. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial
- Hamid Lorvand Amiri
- Shahram Agah
- Javad Tolouei Azar
- Sharieh Hosseini
- Farzad Shidfar
- Seyedeh Neda Mousavi
46. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?
- Asieh Mansour
- Azita Hekmatdoost
- Parvin Mirmiran
47. Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease
- Seyed Reza Mirhafez
- Azam Rezai
- Maryam Dehabeh
- B. Fatemeh Nobakht M. Gh
- Mohammad Bidkhori
- Amirhosein Sahebkar
- Mitra Hariri
48. Enriching laying hens eggs by feeding diets with different fatty acid composition and antioxidants
- Petru Alexandru Vlaicu
- Tatiana Dumitra Panaite
- Raluca Paula Turcu
49. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysis
- Muhammad Y. Khan
- Albana B. Mihali
- Muhammad S. Rawala
- Aysha Aslam
- Waqas J. Siddiqui
50. Fatty Liver Disease and Gut Microbiota: A Comprehensive Update
- Lyna Campo
- Sara Eiseler
- Tehilla Apfel
- Nikolaos Pyrsopoulos
51. Fructose Consumption is Associated with Non-Alcoholic Fatty Liver Disease Risk: A Case-Control Study from Iran
- Mina Darand
- Zahra Darabi
- Zahra Yari
- Azita Hekmatdoost
52. Joint effect of changes in physical activity and weight on incident non-alcoholic fatty liver disease
- Yi-Lin Tsai
- Sean Chun-Chang Chen
53. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
- Maria Hernandez-Rodas
- Rodrigo Valenzuela
- Luis Videla
54. Egg consumption and risk of non-alcoholic fatty liver disease
- Zeinab Mokhtari
- Hossein Poustchi
- Tannaz Eslamparast
- Azita Hekmatdoost
55. Ability of dairy fat in inducing metabolic syndrome in rats
- Elham Ehrampoush
- Reza Homayounfar
- Sayed Hossein Davoodi
- Hamid Zand
- Alireza Askari
- Seyed Amin Kouhpayeh
56. The main approaches to dietary changes in non-alcoholic fatty liver disease
- O. M. Drapkina
- R. N. Shepel
- A. V. Starodubova
- Yu. V. Evsutina